Cipta Sarana Medika Tbk. vs Bank Multiarta Sentosa Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Bank Multiarta Sentosa Tbk. trades at Rp3,390 (market cap 4.7T, 9.7K 24h volume). The key difference: Bank Multiarta Sentosa Tbk. is far larger — about 29.7× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 9.7K). Which is the better fit depends on your goals.
| DKHH | MASB | |
|---|---|---|
Market Cap | 158.12B | 4.7T |
Volume | 8.21M | 9.7K |
Lot | 82.15K | 97 |
Turnover | 515.2M | 32.79M |
Average Price | 62.72 | 3,380.21 |
Value | 515.2M | 32.79M |
Indicative Equilibrium Price | 63 | — |
Indicative Equilibrium Volume | 1.33K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.
Read more on MASB →